Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

we are also restating our December 31, 2013 Balance Sheet as it pertains to the Fair Value of our Warrants, Preferred Series C & D and Convertible Debentures to amounts as stated below from how they were reported as of December 31, 2013 in our 10-K: 

	December 31, 2013				December 31, 2013
	(as previously reported)		Adjustments		(Restated)
Derivative Financial Instruments – warrants	$	684	$	(64)	$	620
Derivative Financial Instruments – Series C and D PS and DP	$	23,606	$	(23,310)	$	296
Debentures payable – carried at fair value	$	257,451	$	(219,201)	$	38,250
Total Liabilities	$	284,576	$	(242,575)	$	42,001
Accumulated deficit	$	(479,485)	$	242,575	$	(236,910)
Total shareholders’ deficit	$	(284,435)	$	242,575	$	(41,860)

Schedule of Derivative Instruments [Table Text Block]

The table below reflects the changes in restating the derivative liabilities for the three months ended March 31, 2014 (in thousands):

Derivative Liability Restatement for the 3 months ended March 31, 2014:

	3 Months. March 31, 2014				3 Months. March 31, 2014
	(as previously reported)		Adjustments		(Restated)
Gain (loss) from change in fair value of hybrid financial instruments	$	218,656	$	(219,201)	$	(545)
Gain (loss) from change in fair value of derivative liability – warrants	$	437	$	(64)	$	373
Gain (loss) from change in fair value of derivative liability – Series C & D	$	23,447	$	(23,310)	$	137
Net income	$	242,590	$	(242,575)	$	15
Net income available to common shareholders	$	242,590	$	(242,575)	$	15
Comprehensive income	$	242,590	$	(242,575)	$	15

Derivative Liability Restatement for the 3 months ended March 31, 2013:

	3 Months. March 31, 2013				3 Months. March 31, 2013
	(as previously reported)		Adjustments		(Restated)
Gain (loss) from change in fair value of hybrid financial instruments	$	6,774	$	17,713	$	24,487
Gain (loss) from change in fair value of derivative liability – warrants	$	3,122	$	44	$	3,166
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(299)	$	2,242	$	1,943
Net income	$	9,038	$	19,999	$	29,037
Net income available to common shareholders	$	9,038	$	19,999	$	29,037
Comprehensive income	$	9,149	$	19,999	$	29,148

Schedule Of Derivative Instruments In Statement Of Cash Flows Fair Value [Table Text Block]

Statement of Cash Flow:

	3 Months. March 31, 2014				3 Months. March 31, 2014
	(as previously reported)		Adjustments		(Restated)
Net income	$	242,590	$	(242,575)	$	15
Gain (loss) from change in fair value of hybrid financial instruments	$	(218,656)	$	219,201	$	545
Gain (loss) from change in fair value of derivative liability – warrants	$	(437)	$	64	$	(373)
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(23,447)	$	23,310	$	(137)
Net cash used in operating activities	$	27	$	-	$	27

	3 Months. March 31, 2013				3 Months. March 31, 2013
	(as previously reported)		Adjustments		(Restated)
Net income	$	9,038	$	19,999	$	29,037
Gain (loss) from change in fair value of hybrid financial instruments	$	(6,774)	$	(17,713)	$	(24,487)
Gain (loss) from change in fair value of derivative liability – warrants	$	(3,122)	$	(44)	$	(3,166)
Gain (loss) from change in fair value of derivative liability – Series C & D	$	299	$	(2,242)	$	(1,943)
Net cash used in operating activities	$	(547)	$	-	$	(547)

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The components of basic and diluted income per share attributable to the Company’s common stock shareholders were as follows (in thousands, except share and per share data): 

	Three Months Ended
	March 31,
	2014		2013
		(RESTATED)	(RESTATED)
Numerator:
Net income available to common shareholders	$	15	$	29,037
Effect of dilutive securities:
Hybrid financial instruments		(545)		(24,487)
Derivative liability - warrants		373		3,166
Derivative liability - Series C and D Convertible
Preferred Stock and debentures		137		1,943
Numerator for diluted income per common share	$	(20)	$	9,659
Denominator:
Weighted average shares used to compute basic income per common share		4,984,827,279		2,789,315,439
Effect of dilutive securities:
Hybrid financial instruments		233,957,214,103		32,949,714
Derivative liability - warrants		440,652,725		2,083,292
Derivative liability - Series C and D preferred stock and debentures		26,618,556,701		3,398,694
Denominator for diluted income per common share		266,001,250,808		27,931,664,140
Basic income per common share	$	0.000	$	0.010
Diluted income per common share	$	0.000	$	0.001